To detect GLP-1R activity in the ex-vivo assay over a sufficient period of time for accurate half-life determination, the dose of the glycosylated variant in the PK stability experiment had to be increased to 40 mg/kg compared to 5 mg/kg for the non-glycosylated fusion
Atrial Natriuretic peptide attenuates colitis via inhibition of the cGAS-STING pathway in colonic epithelial cells
Carriers of the A allele were determined to have a 2.9-fold greater risk of developing dose-related atorvastatin ADRs ( p = 0.016) (Mirosevic Skvrce et al., 2015)
But as GLP-1 therapies continue to help patients achieve significant, life changing weight loss, another conversation is gaining attention and it deserves just as much care and expertise
Caduet carved out a niche in patients requiring both a statin and an antihypertensive, but it did not capture a large enough share of the Lipitor prescribing base to meaningfully offset the revenue loss from atorvastatins genericization
The activation of pro-migratory signals (FAKpaxillin) and pro-angiogenic factors (VEGF, EGR-1, nitric oxide) by BPC-157is a double-edged sword